Trial intelligence / Profile preview

Cisapride for Diabetic Gastroparesis Exacerbations

NCT01286090Phase 4Terminated

Sponsor
Johnson & Johnson
Start
Jul 2003
Modality
Small Molecules
01

Overview

A Phase 4 trial of cisapride in gastroparesis, sponsored by Johnson & Johnson. Started Jul 2003; status: terminated.

02

Drugs

cisapride
03

Conditions

gastroparesis

Beyond the preview

Go deeper on NCT01286090.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01286090.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call